New basic concepts in microbiome management and ecology including targeted organisms, multi-organism (systems) strategies, computational microbiomics, and support environment/matrix strategies
Initially, efficacious and cost-effective, user-appropriate anti-MRSA and v-MSSA products for hospital, outpatient, and consumer environments
BioPlx is an advanced microbiomics company developing non-antibiotic methods for the control of infectious disease, including multiple-drug resistant “super-bugs”. The company employs targeted microbiological agents along with nutrient, and signaling factors to create unique and protectable formulations
BioPlx is initially focused on control of hospital (HA) and community acquired (CA) dermal (exobiomic) disease, particularly:
… with an emphasis on preventing recurrence and re-infection.
Product lines that satisfy medical practice, reimbursement, patient requirement, and public health objectives, while reducing disease recurrence and care provider liability/risk
World health leaders have described antibiotic-resistant microorganisms as “nightmare bacteria” that “pose a catastrophic threat” to people in every country in the world
- Antibiotic Resistance Threats in the United States, 2013 - CDC
Coordinated efforts to implement new policies, renew research efforts,
and pursue steps to manage the crisis are greatly needed.
- The Antibiotic Resistance Crisis, 2015 - CDC
Every year, more than two million people in the United States get infections that are resistant to antibiotics and at least 23,000 people die as a result (conservative estimate)
- Untreatable: Today’s Drug-Resistant Health Threats, 2015 - CDC
Without urgent, coordinated action the world is headed for a post-antibiotic era, in which common infections and minor injuries which have been treatable for decades can once again kill.
- Global Report on Antibiotic Resistance, 2014 - WHO
MRSA infections can be very serious, and are among
the most frequently occurring of all antibiotic-resistant threats.
- The Antibiotic Resistance Crisis, 2015 - P&T
Map functional intra-biome relationships to create transitional -> stable desired populations
Very high capacity computational and analytic methods to extract and correlate global data sets
Development of specialized organisms with known attributes too occupy specific biome niches
Additional nutrient, signaling, and selective agents included to improve biome management
Materials and structures used to contain, sustain, preserve, and administer biome formulations
Handling and product use characteristics required for HA, OP, and CA market segments
BioPlx is a highly connected global organization, led by an exceptionally qualified management team and board with deep technical, entrepreneurial, and business experience. The company makes maximum use of new information and computational technologies to achieve cutting-edge technical and business strategies. The organization is designed to use both in-house and proprietary contract development and consulting strategies across the wide range of components and methods incorporated within this product line
Next-generation microbiome management
Defeating antibiotic resistance
anti-MRSA, v-MSSA products